POELLATH advises the management of Primed Group on its sale to Inflexion

European private equity firm Inflexion has acquired Primed Group, a leading German provider of high-quality medical products and sterilisation services. The seller is Paragon Partners, a private equity firm focused on the DACH region. The investment is being made through Inflexion Buyout Fund VI and represents Inflexion’s sixth investment in the DACH region. Completion of the transaction remains subject to customary regulatory approvals. POELLATH provided legal advice to the management team of Primed Group in connection with the transaction.

Headquartered in Halberstadt, Germany, Primed Group covers the entire value chain, from product development and manufacturing to distribution. With around 470 employees, the company develops and produces innovative, certified medical products at several locations, serving customers in more than 60 countries worldwide.

Inflexion is a leading European mid-market private equity firm that invests in high-growth businesses and supports management teams in driving their continued development and expansion.

With a focus on established medium-sized businesses in the German-speaking region, Paragon Partners invests in companies with significant strategic and operational development potential. Together with its portfolio companies, the firm pursues sustainable growth and value-creation strategies.

POELLATH provided legal advice to the management team of Primed Group in connection with the transaction with the following Munich-based team:

• Dr. Benedikt Hohaus (partner, management participation, M&A/PE)
• Silke Simmer (counsel, management participation, M&A/PE)
• Nicole Kaltenberg (senior associate, employment law, M&A/PE)
• Natalie Tafelski (associate, management participation, M&A/PE)